Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment
PLOS One · 06.11.2026 · 21 (11) · e0361954
DOI: 10.1371/journal.pone.0361954 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.11.2026. Verfasst von Shotaro Harada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Graduate School of Medicine, The University of Osaka, Suita, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Silicon, Vestibular Diseases, Arthritis, Experimental. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and progressive disability. Although current therapies have improved clinical outcomes, safer and more effective therapeutic approaches remain needed. Silicon (Si)-based agents have antioxidant and anti-inflammatory properties and have shown beneficial effects in several inflammatory disease models.
Methods
We evaluated the effects of oral administration of a Si-based agent in a type II collagen-induced arthritis mouse model. Arthritis severity was assessed using an arthritis index, hindlimb oedema, and the hindlimb extension reflex test. Serum type II collagen-specific autoantibody levels were also measured. Vestibular function was evaluated using the vestibulo-ocular reflex (VOR), and inner-ear structural changes were assessed by magnetic resonance imaging and histological analysis.
Results
The Si-based agent reduced arthritis-related outcomes, including the arthritis index, hindlimb oedema, and joint movement restriction, and reduced serum type II collagen-specific autoantibody levels. In contrast, no significant differences between the Si-based agent and control groups were detected in VOR-related outcomes, endolymphatic space measurements, or inner-ear histological findings.
Conclusions
These findings suggest that the Si-based agent may have beneficial effects on arthritis-related manifestations. However, its effects on the vestibular function-related outcomes examined in this study were not evident. Further studies are needed to clarify the relationship between RA and vestibular dysfunction and to determine the potential therapeutic effects of Si-based agent on these complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Graduate School of Medicine, The University of Osaka, Suita, Japan.
- Department of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
- Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka, Japan.
- SANKEN, The University of Osaka, Suita, Japan.
- Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan.
- Institute for Biomedical Sciences, Iwate Medical University, Morioka, Japan.
ORCID-Profile: Yoshihisa Koyama
Förderung
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Harada, S., Koyama, Y., Kobayashi, Y., Imai, T., Yoshioka, Y., Kobayashi, H., Inohara, H., & Shimada, S. (2026). Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment. PLOS One, 21(11), e0361954. https://doi.org/10.1371/journal.pone.0361954
Vancouver
Harada S, Koyama Y, Kobayashi Y, Imai T, Yoshioka Y, Kobayashi H, et al. Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment. PLOS One. 2026;21(11):e0361954. doi:10.1371/journal.pone.0361954
BibTeX
@article{Harada2026,
author = {Harada, Shotaro and Koyama, Yoshihisa and Kobayashi, Yuki and Imai, Takao and Yoshioka, Yoshichika and Kobayashi, Hikaru and Inohara, Hidenori and Shimada, Shoichi},
title = {Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361954},
doi = {10.1371/journal.pone.0361954}
}
EUVIMED